NEWRON PHARMACEUT. EO-,20

20.95
0.72 %

Newron Pharmaceuticals is a biotechnology company focused on developing drugs for the treatment of central nervous system disorders.

Performance & Momentum

6 Months 111.46 %
1 Year 117.41 %
3 Years 236.29 %
5 Years 695.80 %

Similar stocks to NEWRON PHARMACEUT. EO-,20

Anantys Community

Be the first to share your analysis on NEWRON PHARMACEUT. EO-,20.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases